Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project
11/03/2026 13:51
March 11 (Reuters) - Ryvu Therapeutics SA RVU.WA: SIGNS GRANT AGREEMENT WITH POLAND'S NATIONAL CENTRE FOR RESEARCH AND DEVELOPMENT (NCBR) FOR PERO PROJECT TOTAL NET VALUE OF PERO PROJECT IS PLN 32.35 MILLION, RECOMMENDED GRANT FUNDING FOR PERO PROJECT IS PLN 19.96 MILLION Source text: ID:nEM2q7rHPa Further company coverage: RVU.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project